🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/06/1985 0,0212 USD
28/02/1985 0,0212 USD
03/12/1984 0,0212 USD
31/08/1984 0,0199 USD
29/05/1984 0,0199 USD
01/03/1984 0,0199 USD
29/11/1983 0,0199 USD
29/08/1983 0,0186 USD
31/05/1983 0,0186 USD
28/02/1983 0,0186 USD
30/11/1982 0,0186 USD
30/08/1982 0,0186 USD
01/06/1982 0,0186 USD
01/03/1982 0,0186 USD
01/12/1981 0,0186 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/04/1991 17,95 18,41 17,93 18,25 +1,55% 2,66% 4.858.738
16/04/1991 17,49 17,97 17,43 17,97 +3,08% 3,07% 4.942.997
15/04/1991 17,29 17,47 17,28 17,43 +1,04% 1,15% 2.823.941
12/04/1991 17,31 17,37 17,14 17,26 +0,23% 1,38% 2.700.067
11/04/1991 17,04 17,33 17,04 17,22 +1,52% 1,75% 2.551.670
10/04/1991 16,94 17,04 16,86 16,96 +0,00% 1,06% 2.487.533
09/04/1991 17,18 17,28 16,92 16,96 -1,27% 2,08% 3.184.872
08/04/1991 16,98 17,29 16,94 17,18 +1,17% 2,11% 2.416.478
05/04/1991 17,29 17,35 16,88 16,98 -1,50% 2,76% 3.725.640
04/04/1991 17,26 17,45 17,12 17,24 -0,12% 1,96% 3.423.816
03/04/1991 17,35 17,41 17,24 17,26 -0,23% 1,03% 3.596.736
02/04/1991 16,86 17,29 16,84 17,29 +3,08% 2,71% 2.848.464
01/04/1991 16,70 16,78 16,64 16,78 +0,00% 0,83% 3.264.101
28/03/1991 16,96 16,98 16,74 16,78 -1,06% 1,41% 1.998.326
27/03/1991 17,24 17,28 16,86 16,96 -1,39% 2,42% 3.924.341
26/03/1991 16,58 17,20 16,56 17,20 +3,59% 3,84% 4.080.912
25/03/1991 16,52 16,66 16,44 16,60 +0,60% 1,32% 2.097.048
22/03/1991 16,40 16,52 16,32 16,50 +0,73% 1,21% 2.954.102
21/03/1991 16,56 16,64 16,30 16,38 -0,72% 2,04% 4.040.040
20/03/1991 16,22 16,54 16,18 16,50 +2,22% 2,21% 5.551.046
19/03/1991 16,66 16,66 15,82 16,14 -4,13% 5,01% 8.057.443
18/03/1991 17,06 17,20 16,64 16,84 -1,97% 3,26% 5.056.810
15/03/1991 17,24 17,26 17,02 17,18 +0,12% 1,38% 8.589.408
14/03/1991 16,98 17,33 16,94 17,16 +1,77% 2,34% 6.099.989
13/03/1991 16,78 16,96 16,62 16,86 +0,47% 2,01% 2.558.587
12/03/1991 16,98 17,12 16,74 16,78 -1,17% 2,22% 4.825.411
11/03/1991 16,82 17,10 16,80 16,98 +1,07% 1,77% 3.186.758
08/03/1991 16,60 17,10 16,56 16,80 +1,32% 3,23% 4.594.642
07/03/1991 16,32 16,68 16,32 16,58 +0,85% 2,19% 3.175.440
06/03/1991 16,60 16,62 16,40 16,44 -0,60% 1,32% 4.236.226